BioSpace News Archive

Policy

Bristol-Myers Squibb Issues Statement on Celgene’s Settlement with Alvogen on Revlimid® Patent Litigation

Bristol-Myers Squibb Company (NYSE:BMY) today issued the following statement regarding Celgene’s (NASDAQ:CELG) settlement with Lotus Pharmaceutical Co., Ltd. and Alvogen Pine Brook, LLC (collectively, “Alvogen”) relating to patents for Revlimid

March 29, 2019
·
13 min read
Pharm Country

Combination Liposuction Modalities Yield Superior Body Sculpting Capabilities And Increased Patient Satisfaction

Dr. Cap Lesesne of International Cosmetic Surgery in New York City announces a new body contouring treatment combining ultrasonic skin tightening technology with power assisted liposuction resulting in the ultimate body sculpting for both men and women.

March 29, 2019
·
1 min read
Pharm Country

Mareana Included in Gartner Research: Cited Among “Clinical Vendors Building Value with AI Technology”

Mareana announced that it has been included in Gartner’s January 17, 2019 artificial intelligence research note, Life Sciences CIOs, Accelerate Clinical Development with New Applications of Artificial Intelligence, written by analysts Jeff Smith and Michael Shanler.

March 29, 2019
·
4 min read
Business

More than 200 Diabetes Advocates convene in Washington D.C. to advocate on the Hill for affordable insulin; other policy-driven diabetes issues

This week, Diabetes Advocates from around the country gathered in D.C. for the American Diabetes Association’s Call to Congress, an annual gathering on Capitol Hill to educate members of Congress about the impacts of diabetes and advocate for key federal priorities.

March 29, 2019
·
4 min read
Biotech Bay

Alliance for Smiles Celebrates 15 Years of “Repairing Children’s Smiles” with Gala April 6 and Announces International Missions

Sometimes your joy is the source of your smile,” opines Zen master Thích Nhất Hạnh. “But sometimes your smile can be the source of your joy.

March 29, 2019
·
2 min read
Deals

Can-Fite Files Annual Report for the Year Ended December 31, 2018

Can-Fite BioPharma Ltd. announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2018 with the U.S. Securities and Exchange Commission.

March 29, 2019
·
2 min read
Aqualitas Receives Sales Licence under Health Canada’s Cannabis Act

Aqualitas Inc. (Aqualitas), a licensed producer of certified organically grown cannabis, is pleased to announce that it has been awarded a sales licence by Health Canada.

March 29, 2019
·
1 min read
Policy

Wolf Popper LLP Announces That It Has Filed A Securities Class Action Lawsuit Against First Choice Healthcare Solutions and its Former CEO Christian Romandetti

Wolf Popper LLP announced that it has filed a securities class action lawsuit in the United States District Court for the Middle District of Florida against First Choice Healthcare Solutions, Inc. and its former Chairman, CEO, and President Christian Romandetti, Sr.

March 29, 2019
·
2 min read
Policy

ADA’s William T. Cefalu, MD, to Testify on the Rising Cost of Insulin Before the Oversight and Investigations Subcommittee of the U.S. House of Representatives’ Committee on Energy & Commerce on Tuesday, April 2

The American Diabetes Association’s Chief Scientific, Medical and Mission Officer, William T. Cefalu, MD, will testify before the U.S. House of Representatives Committee on Energy & Commerce’s Oversight and Investigations Subcommittee

March 29, 2019
·
3 min read
Policy

ThermoLife International Sues Olympus Labs For Alleged False Advertising Of VASO6, And For Selling Dietary Supplements Allegedly Spiked With The Drug DMHA

On March 27, 2019, ThermoLife International, LLC filed suit in Arizona Federal District Court against Olympus Labs. ThermoLife’s Complaint brings claims against Olympus Labs for false advertising under 25 U.S.C. § 1125(d), false marking under 35 U.S.C. § 292 and unfair competition.

March 29, 2019
·
2 min read